Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1054

1.

Female Hormonal Factors and the Risk of Endometrial Cancer in Lynch Syndrome.

Dashti SG, Chau R, Ouakrim DA, Buchanan DD, Clendenning M, Young JP, Winship IM, Arnold J, Ahnen DJ, Haile RW, Casey G, Gallinger S, Thibodeau SN, Lindor NM, Le Marchand L, Newcomb PA, Potter JD, Baron JA, Hopper JL, Jenkins MA, Win AK.

JAMA. 2015 Jul 7;314(1):61-71. doi: 10.1001/jama.2015.6789.

PMID:
26151267
2.

Activating ERBB2/HER2 mutations indicate susceptibility to pan-HER inhibitors in Lynch and Lynch-like colorectal cancer.

Kloth M, Ruesseler V, Engel C, Koenig K, Peifer M, Mariotti E, Kuenstlinger H, Florin A, Rommerscheidt-Fuss U, Koitzsch U, Wodtke C, Ueckeroth F, Holzapfel S, Aretz S, Propping P, Loeffler M, Merkelbach-Bruse S, Odenthal M, Friedrichs N, Heukamp LC, Zander T, Buettner R.

Gut. 2015 Apr 28. pii: gutjnl-2014-309026. doi: 10.1136/gutjnl-2014-309026. [Epub ahead of print]

PMID:
26001389
3.

[Molecular characterization of Lynch syndrome in Tunisia].

Sana A, Farid Z, Amel M, Nadia K, Amel M, Nabil A, Taoufik N, Farhat BA, Sarah BJ, Mohamed M, Marie-Pierre B.

Tunis Med. 2014 Jul;92(7):458-62. French.

4.

Origin of MLH1, MSH2, MSH6 and PMS2 mutations can help inform long-term care strategies for patients with colorectal and endometrial cancer.

Hickmott JW.

Clin Genet. 2015 Jun;87(6):534-5. doi: 10.1111/cge.12584. Epub 2015 Apr 6. No abstract available.

PMID:
25761822
5.

Establishing cancer risks associated with PMS2 germline mutations in Lynch syndrome.

Caron NS.

Clin Genet. 2015 Jun;87(6):533-4. doi: 10.1111/cge.12583. Epub 2015 Apr 6. No abstract available.

PMID:
25761717
6.

A modified Lynch syndrome screening algorithm in colon cancer: BRAF immunohistochemistry is efficacious and cost beneficial.

Roth RM, Hampel H, Arnold CA, Yearsley MM, Marsh WL, Frankel WL.

Am J Clin Pathol. 2015 Mar;143(3):336-43. doi: 10.1309/AJCP4D7RXOBHLKGJ.

PMID:
25696791
7.

Relationship between smoking and multiple colorectal cancers in patients with Japanese Lynch syndrome: a cross-sectional study conducted by the Japanese Society for Cancer of the Colon and Rectum.

Tanakaya K, Furukawa Y, Nakamura Y, Hirata K, Tomita N, Tamura K, Sugano K, Ishioka C, Yoshida T, Ishida H, Watanabe T, Sugihara K; HNPCC registry and genetic testing project of the Japanese Society for Cancer of the Colon and Rectum, Yamaguchi T, Ishikawa H, Matsubara N, Arai M, Moriya Y.

Jpn J Clin Oncol. 2015 Mar;45(3):307-10. doi: 10.1093/jjco/hyu218. Epub 2015 Jan 12.

PMID:
25583420
8.

Clinical management of hereditary colorectal cancer syndromes.

Vasen HF, Tomlinson I, Castells A.

Nat Rev Gastroenterol Hepatol. 2015 Feb;12(2):88-97. doi: 10.1038/nrgastro.2014.229. Epub 2015 Jan 13. Review.

PMID:
25582351
9.

RNA. Prescribing splicing.

Guigó R, Valcárcel J.

Science. 2015 Jan 9;347(6218):124-5. doi: 10.1126/science.aaa4864. No abstract available.

PMID:
25574005
10.

New strategies immediately needed for molecular marker reporting in colorectal cancer.

Sussman DA, Hernandez MN, Tannenbaum SL, Bonner JM, McClure LA, Lee DJ.

Am J Gastroenterol. 2015 Jan;110(1):197-8. doi: 10.1038/ajg.2014.360. No abstract available.

PMID:
25567180
11.

RNA splicing. The human splicing code reveals new insights into the genetic determinants of disease.

Xiong HY, Alipanahi B, Lee LJ, Bretschneider H, Merico D, Yuen RK, Hua Y, Gueroussov S, Najafabadi HS, Hughes TR, Morris Q, Barash Y, Krainer AR, Jojic N, Scherer SW, Blencowe BJ, Frey BJ.

Science. 2015 Jan 9;347(6218):1254806. doi: 10.1126/science.1254806. Epub 2014 Dec 18.

PMID:
25525159
12.

Establishing a clinical and molecular diagnosis for hereditary colorectal cancer syndromes: Present tense, future perfect?

Jansen M, Menko FH, Brosens LA, Giardiello FM, Offerhaus GJ.

Gastrointest Endosc. 2014 Dec;80(6):1145-55. doi: 10.1016/j.gie.2014.07.049. Review. No abstract available.

PMID:
25434663
13.

Role of microsatellite instability-low as a diagnostic biomarker of Lynch syndrome in colorectal cancer.

Vilar E, Mork ME, Cuddy A, Borras E, Bannon SA, Taggart MW, Ying J, Broaddus RR, Luthra R, Rodriguez-Bigas MA, Lynch PM, You YQ.

Cancer Genet. 2014 Oct-Dec;207(10-12):495-502. doi: 10.1016/j.cancergen.2014.10.002. Epub 2014 Oct 13.

PMID:
25432668
14.

Comparison of clinical features between suspected familial colorectal cancer type X and Lynch syndrome in Japanese patients with colorectal cancer: a cross-sectional study conducted by the Japanese Society for Cancer of the Colon and Rectum.

Yamaguchi T, Furukawa Y, Nakamura Y, Matsubara N, Ishikawa H, Arai M, Tomita N, Tamura K, Sugano K, Ishioka C, Yoshida T, Moriya Y, Ishida H, Watanabe T, Sugihara K; HNPCC Registry and Genetic Testing Project of the Japanese Society for Cancer of the Colon and Rectum.

Jpn J Clin Oncol. 2015 Feb;45(2):153-9. doi: 10.1093/jjco/hyu190. Epub 2014 Nov 17.

PMID:
25404568
15.

Early-onset colorectal cancer: a sporadic or inherited disease?

Stigliano V, Sanchez-Mete L, Martayan A, Anti M.

World J Gastroenterol. 2014 Sep 21;20(35):12420-30. doi: 10.3748/wjg.v20.i35.12420. Review.

16.

Polymerase ɛ (POLE) mutations in endometrial cancer: clinical outcomes and implications for Lynch syndrome testing.

Billingsley CC, Cohn DE, Mutch DG, Stephens JA, Suarez AA, Goodfellow PJ.

Cancer. 2015 Feb 1;121(3):386-94. doi: 10.1002/cncr.29046. Epub 2014 Sep 15.

PMID:
25224212
17.

Molecular screening in Sicilian families with hereditary non-poliposis colorectal cancer (H.N.P.C.C.) syndrome: identification of a novel mutation in MSH2 gene.

Cavallaro A, Russo A, Catania VE, Ficili B, Romano F, Failla AV, Cappellani A, Cammisuli F, Viola M, Madeddu R, Trichilo V, Libra M, Travali S.

Int J Surg. 2014;12 Suppl 2:S120-4. doi: 10.1016/j.ijsu.2014.08.366. Epub 2014 Sep 6.

PMID:
25200962
18.

Synchronous gastric and sebaceous cancers, a rare manifestation of MLH1-related Muir-Torre syndrome.

Svec J, Schwarzová L, Janošíková B, Stekrová J, Mandys V, Kment M, Vodička P.

Int J Clin Exp Pathol. 2014 Jul 15;7(8):5196-202. eCollection 2014.

19.

Somatic aberrations of mismatch repair genes as a cause of microsatellite-unstable cancers.

Geurts-Giele WR, Leenen CH, Dubbink HJ, Meijssen IC, Post E, Sleddens HF, Kuipers EJ, Goverde A, van den Ouweland AM, van Lier MG, Steyerberg EW, van Leerdam ME, Wagner A, Dinjens WN.

J Pathol. 2014 Dec;234(4):548-59. doi: 10.1002/path.4419. Epub 2014 Sep 30.

PMID:
25111426
20.

MLH1 and MSH2 mutation screening in HNPCC families of Hungary - Two new MMR gene mutations.

Tanyi M, Olasz J, Tanyi JL, Tóth L, Antal-Szalmás P, Ress Z, Bubán T, Palatka K, András C, Urbancsek H, Garami Z, Csuka O, Damjanovich L.

Eur J Surg Oncol. 2014 Nov;40(11):1445-52. doi: 10.1016/j.ejso.2014.07.032. Epub 2014 Jul 24.

PMID:
25107687
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk